SCHEMBL8857239

SCHEMBL8857239

CCC(O)N1CCOC(COc2cccc(Cl)c2)C1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.55
DRD4 P21917 7/20 0.51
ACLY P53396 1/20 0.45
GRM2 Q14416 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974642 0.86 HRH3 (0.59) HRH3DRD4ACLY
SCHEMBL14018436 0.80 DRD4 (0.57) HRH3DRD4GRM2
SCHEMBL8857140 0.76 GRM2 (0.60) GRM2
SCHEMBL8857512 0.76 GRM2 (0.60) GRM2
SCHEMBL8857271 0.76 GRM2 (0.60) GRM2
SCHEMBL8857234 0.75 DRD4 (0.57) DRD4
SCHEMBL22003799 0.71 HRH3 (1.00) HRH3DRD4
SCHEMBL5513197 0.71 ALDH1A1 (0.77) DRD4GRM2
SCHEMBL6487223 0.71 ALDH1A1 (0.77) DRD4GRM2
SCHEMBL5997443 0.71 ALDH1A1 (0.77) DRD4GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688823-A ANTILIPEMIC AGENTS, ANTIGLYCEMIC AGENTS, OBESITY, GLUCOSE TOLERANCE INSUFFICIENCY, INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1997-11-18 US disclosed